inspection – Page 235

Unplanned hold time extension during scale-up – CAPA ineffectiveness identified

Addressing Unplanned Hold Time Extensions in Pharmaceutical Scale-Up Processes Unplanned hold time extensions during the scale-up of pharmaceutical manufacturing processes can lead to significant regulatory challenges and product quality concerns.…

Audit Failures and Repeat Findings? Corporate Compliance Solutions

Addressing Audit Failures and Recurring Findings in Pharmaceutical Compliance Audit failures can pose significant challenges for pharmaceutical organizations, impacting their compliance status and operational integrity. Understanding the nuances behind these…

Visual Inspection Missing Residues? Improving Effectiveness and Inspector Training

Addressing Visual Inspection Failures: Enhancing Effectiveness and Inspector Training Visual inspection failures are a persistent challenge in pharmaceutical manufacturing, impacting product quality and compliance standards. If residue is overlooked during…